BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18330456)

  • 1. Implication of the polyamine system in mental disorders.
    Fiori LM; Turecki G
    J Psychiatry Neurosci; 2008 Mar; 33(2):102-10. PubMed ID: 18330456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide.
    Fiori LM; Wanner B; Jomphe V; Croteau J; Vitaro F; Tremblay RE; Bureau A; Turecki G
    PLoS One; 2010 Nov; 5(11):e15146. PubMed ID: 21152090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polyamines and mental diseases].
    Siatkin SP; Svinarev VI; Zaletok SP; Fedoronchuk TV; Berezov TT
    Vestn Ross Akad Med Nauk; 2006; (2):45-51. PubMed ID: 16544905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamines and polyamine-metabolizing enzymes in schizophrenia: Current knowledge and concepts of therapy.
    Bernstein HG; Keilhoff G; Laube G; Dobrowolny H; Steiner J
    World J Psychiatry; 2021 Dec; 11(12):1177-1190. PubMed ID: 35070769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
    Krystal JH; Tolin DF; Sanacora G; Castner SA; Williams GV; Aikins DE; Hoffman RE; D'Souza DC
    Drug Discov Today; 2009 Jul; 14(13-14):690-7. PubMed ID: 19460458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychopharmacological treatment of suicidal process].
    Mussa A
    Vertex; 2011; 22(100):435-43. PubMed ID: 22799145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
    Ivanova SA; Losenkov IS; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system in mental disorders: Evidence from human brain studies.
    Ibarra-Lecue I; Pilar-Cuéllar F; Muguruza C; Florensa-Zanuy E; Díaz Á; Urigüen L; Castro E; Pazos A; Callado LF
    Biochem Pharmacol; 2018 Nov; 157():97-107. PubMed ID: 30026022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide and the polyamine system.
    Gross JA; Turecki G
    CNS Neurol Disord Drug Targets; 2013 Nov; 12(7):980-8. PubMed ID: 24040803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamines: The possible missing link between mental disorders and epilepsy (Review).
    Baroli G; Sanchez JR; Agostinelli E; Mariottini P; Cervelli M
    Int J Mol Med; 2020 Jan; 45(1):3-9. PubMed ID: 31746386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTR2A: association and expression studies in neuropsychiatric genetics.
    Norton N; Owen MJ
    Ann Med; 2005; 37(2):121-9. PubMed ID: 16026119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology.
    Huang YY; Battistuzzi C; Oquendo MA; Harkavy-Friedman J; Greenhill L; Zalsman G; Brodsky B; Arango V; Brent DA; Mann JJ
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):441-51. PubMed ID: 15469667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of the FGF system in psychiatric disorders.
    Riva MA; Molteni R; Bedogni F; Racagni G; Fumagalli F
    Trends Pharmacol Sci; 2005 May; 26(5):228-31. PubMed ID: 15860368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1983 May; 25(635):45-52. PubMed ID: 6843486
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?
    Naguy A
    J Diet Suppl; 2018 Jan; 15(1):124-128. PubMed ID: 28558251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacotherapy prescription and suicidal behaviour.
    Jagodic HK; Agius M; Pregelj P
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S324-8. PubMed ID: 23995201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system and the treatment of mood and anxiety disorders.
    Hill MN; Gorzalka BB
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):451-8. PubMed ID: 19839936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology in child and adolescent psychiatry: a review of the past five years.
    Campbell M; Spencer EK
    J Am Acad Child Adolesc Psychiatry; 1988 May; 27(3):269-79. PubMed ID: 3288611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.